Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds RSS Feed PharmiWeb Candidate Blog RSS Feed PharmiWeb Client Blog


Press Release

Global Hematological Cancers Market Forecast to 2022 - By Blood Cancer Type, Treatment, Product, Disease & End User - Research and Markets

Research and Markets
Posted on: 20 Sep 16

Research and Markets has announced the addition of the "Global Hematological Cancers Market Analysis 2016 - Forecast to 2022" report to their offering.

This analysis is one of the most accurate studies performed using the combinational analytical tools. The report contains up to date financial data derived from varied research sources to present unique and reliable analysis. Assessment of major trends with potential impact on the market during the next five years, including a deep dive analysis of market segmentation which comprises of sub markets, regional and country level analysis. The report provides a comprehensive outlook about the market share along with strategic recommendations based on the emerging segments.

This report analyzes the global markets for "Hematological Cancers". The market assessment is performed through standard and the tailored research methodology approach. The market overview offers in depth analysis at the regional and country level, for instance North America (U.S., Canada and Mexico), Europe (Germany, France, Italy, U.K. and Spain), Asia-Pacific (China, Japan, India, Australia, South Korea and Rest of APAC) and Rest of the World (Middle East, Africa and Latin America).

Annual estimations and forecasts are provided from the year 2013 to 2022 for each given segment and sub segments.

Companies Mentioned:

  • Karyopharm Therapeutics
  • Johnson & Johnson
  • Roche Diagnostics A/S
  • AbbVie
  • Novartis
  • Kite Pharma
  • Celgene Corporation
  • Abbott Laboratories
  • Beckman Coulter
  • HemoCue AB
  • C. R. Bard, Inc.
  • Siemens AG
  • Sysmex
  • Mindray Medical International Limited
  • Bio-Rad Laboratories, Inc.
  • The Medicine Company
  • Pharmacyclics
  • Horiba, Ltd
  • DiagnoCure Inc.
  • Astellas Pharma US, Inc.

Key Topics Covered:

1 Introduction

2 Executive Summary

3 Market Analysis

4 Porters Five Force Analysis

5 Hematological Cancers Market by Blood Cancer Types

6 Hematological Cancers Market by Treatment

7 Hematological Cancers Market by Product

8 Hematological Cancers Market by Disease

9 Hematological Cancers Market by End User

10 Geographical Segmentation

11 Vendor Landscaping

12 Company Profiles

13 Appendix

For more information about this report visit

Related Topics: Oncology Drugs

View source version on

Business Wire

Last updated on: 20/09/2016

Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.